Melospeech Inc. revolutionizes speech therapy with launch of SLPeaceBot™ and CMSP:B-5
15 December 2024 - 7:51AM
Melospeech Inc., a Woman-owned EdTech and
HealthTech company, proudly announces the launch of its
groundbreaking tools,
SLPeaceBot™ and
The
Communication Milestones Screening Protocol: Birth to Five
(CMSP:B-5)™. Designed to streamline therapy operations and
improve care outcomes, these innovative SaaS solutions aim to
transform the speech therapy industry.
SLPeaceBot™ helps providers save hundreds of hours weekly by
automating time-consuming processes, while CMSP:B-5 addresses
challenges in early intervention services by automating the
screening to report writing process for professionals with
unprecedented efficiency. These tools reflect Melospeech Inc.’s
commitment to empowering providers and enhancing care quality
through cutting-edge technology.
“Launching these tools marks an exciting milestone for
Melospeech Inc.,” said Dr. Givona Sandiford, Founder and CEO. “We
are dedicated to providing accessible, transformative solutions
that improve lives and promote equity in speech therapy
services.”
Founded during the COVID-19 pandemic, Melospeech Inc. began as a
small business focused on internal efficiency. Today, it is an
award-winning company recognized for its innovation, earning
accolades such as the Gold American Business Award
and recognition from the EdTech Awards.
With SLPeaceBot™ and CMSP:B-5, Melospeech Inc. continues its
mission to support providers and families while advancing
inclusivity and access to quality care.
The SLPeaceBot™ launched in November with free access for the
first 5,000 users, and a few spots remain in this limited free
offering before a fair and accessible pricing model is
introduced.
Melospeech PR Team
+19512347550
Hello@melospeech.com